Juan Sahuquillo Selected Research

Brain Contusion

1/2020	Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence.
1/2019	Kir6.2, the Pore-Forming Subunit of ATP-Sensitive K+ Channels, Is Overexpressed in Human Posttraumatic Brain Contusions.
10/2015	Sulfonylurea Receptor 1 in Humans with Post-Traumatic Brain Contusions.
8/2014	Clinical applications of intracranial pressure monitoring in traumatic brain injury : report of the Milan consensus conference.
10/2006	Percutaneous implantation of cerebral microdialysis catheters by twist-drill craniostomy in neurocritical patients: description of the technique and results of a feasibility study in 97 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Sahuquillo Research Topics

Disease

14	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2006
7	Intracranial Hypertension 01/2022 - 04/2007
6	Neoplasms (Cancer) 11/2019 - 02/2012
6	Glioblastoma (Glioblastoma Multiforme) 06/2019 - 04/2009
5	Brain Contusion 01/2020 - 10/2006
4	Edema (Dropsy) 01/2020 - 01/2006
4	Brain Ischemia (Cerebral Ischemia) 01/2020 - 01/2006
4	Hypothermia 12/2019 - 01/2006
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 01/2006
3	Hydrocephalus (Hydrocephaly) 11/2020 - 08/2005
3	Glioma (Gliomas) 01/2019 - 04/2009
3	Contusions 01/2019 - 08/2014
3	Infarction (Infarctions) 01/2017 - 01/2006
3	Brain Edema (Cerebral Edema) 10/2015 - 10/2014
3	Craniocerebral Trauma (Head Injury) 12/2014 - 04/2007
2	Infections 11/2020 - 01/2012
2	Coma (Comas) 12/2019 - 07/2011
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 11/2018
2	Moyamoya Disease (Moya-Moya Disease) 07/2018 - 03/2015
2	Hypoxia (Hypoxemia) 03/2015 - 10/2014
2	Diffuse Brain Injuries (Diffuse Brain Injury) 08/2014 - 10/2006
2	Hematoma 08/2014 - 04/2007
2	Normal Pressure Hydrocephalus 01/2012 - 02/2005
2	Stroke (Strokes) 03/2011 - 01/2006
2	Heart Arrest (Cardiac Arrest) 05/2009 - 01/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2006 - 02/2005
1	Apnea 11/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 11/2021
1	Hypercapnia 11/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Ischemic Stroke 01/2021
1	Medulloblastoma 10/2020
1	Hemorrhage 01/2020
1	Hyperventilation 12/2019
1	Hypocapnia 12/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2018
1	Persistent Vegetative State (Vegetative State) 01/2016
1	Vascular Diseases (Vascular Disease) 11/2014
1	Arteriovenous Malformations (Arteriovenous Malformation) 10/2014
1	Aneurysm (Aneurysms) 10/2014
1	Acute Kidney Injury (Acute Renal Failure) 10/2014
1	Ischemia 01/2014
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2012
1	Subdural Hematoma (Subdural Hemorrhage) 01/2012
1	Obesity 01/2012
1	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 01/2012
1	Headache Disorders (Headache Syndromes) 01/2012

Drug/Important Bio-Agent (IBA)

5	Oxygen (Dioxygen)IBA 01/2020 - 01/2007
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2007
3	Sulfonylurea ReceptorsIBA 01/2020 - 10/2015
3	Neoplasm Antigens (Tumor Antigens)IBA 06/2019 - 11/2018
3	AntigensIBA 01/2019 - 11/2018
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2014
2	Glyburide (Glibenclamide)FDA LinkGeneric 01/2020 - 01/2019
2	Peptides (Polypeptides)IBA 01/2019 - 11/2018
2	ProteomeIBA 01/2019 - 11/2018
2	Indicators and Reagents (Reagents)IBA 10/2014 - 04/2007
2	2- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA 10/2014 - 07/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2014 - 04/2007
2	Neuroprotective AgentsIBA 01/2007 - 01/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2006 - 02/2005
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Mannitol (Osmitrol)FDA LinkGeneric 12/2019
1	BarbituratesIBA 12/2019
1	barbituric acid (barbiturate)IBA 12/2019
1	Neutralizing AntibodiesIBA 11/2019
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Transient Receptor Potential ChannelsIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	OligodeoxyribonucleotidesIBA 01/2019
1	HLA-A*24:02 antigenIBA 01/2019
1	VaccinesIBA 01/2019
1	Circulating Tumor DNAIBA 01/2018
1	triphenyltetrazoliumIBA 01/2017
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 11/2015
1	Ion Channels (Ion Channel)IBA 10/2015
1	IonsIBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2014
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 10/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2014
1	4-amino-tetrahydrobiopterinIBA 10/2014
1	Pyruvic Acid (Pyruvate)IBA 01/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012
1	OrexinsIBA 01/2012
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2011

Therapy/Procedure

8	Decompressive Craniectomy 01/2022 - 04/2013
7	Catheters 11/2020 - 10/2006
6	Therapeutics 11/2021 - 01/2006
3	Operative Surgical Procedures 11/2020 - 11/2014
3	Immunotherapy 11/2019 - 11/2018
2	Cerebral Revascularization 07/2018 - 03/2015
1	Craniotomy 01/2022
1	Continuous Positive Airway Pressure 11/2021
1	Aftercare (After-Treatment) 01/2012
1	Conservative Treatment 07/2009